PDK1 and non-small cell lung carcinoma: Our study showed that downregulation of PDK1 combined with TKI treatment strongly enhances oxidative phosphorylation through the upregulation of OXPHOS and reduction in glycolysis, resulting in an increase in ATP production and reduced glucose external supply in oncogene-driven NSCLC cell lines.